Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 06, 2026
Palantir Technologies (PLTR): Can It Reclaim the $200 Level?

Palantir Technologies (PLTR): Can It Reclaim the $200 Level?

Key Takeaways

  • Target in focus: Investors are actively asking whether Palantir Technologies Inc. (PLTR) can reclaim the $200 level, a psychologically significant threshold just below its all-time high of $207.18.
  • Bullish engine: Revenue growth accelerated for nine consecutive quarters, with Q1 2026 revenue surging 85% year-over-year to $1.63 billion, driven by the artificial intelligence platform (AIP) and expanding commercial adoption.
  • Valuation risk: PLTR trades at approximately 138 times trailing earnings and roughly 60 times sales, leaving almost no margin for error if growth decelerates or guidance disappoints.
  • Support and resistance: Key support sits near $107 (the 52-week low), while $150–$160 represents near-term resistance; $200 is the major psychological barrier that must be cleared.
  • Bottom line: Reaching $200 is achievable if Palantir sustains exceptional execution, but the path depends heavily on continued AI spending momentum and multiple compression remaining orderly rather than violent.

Why the $200 Level Draws So Much Attention

The $200 price point carries outsized significance for Palantir shareholders. In November 2025, the stock peaked at $207.18 before entering a prolonged correction that erased more than 40% of its value. Since then, PLTR has traded mostly between $107 and $160, making $200 the symbolic line that separates the post-correction recovery from a genuine return to peak valuation territory. For retail investors who bought near the highs, $200 represents a breakeven milestone. For institutional buyers who accumulated during the pullback, it marks a potential inflection point where conviction meets reward.

Palantir’s Business and Market Position Today

Palantir Technologies builds and deploys software platforms—Gotham, Foundry, and the AIP (Artificial Intelligence Platform)—that help government agencies and commercial enterprises integrate massive datasets, apply machine learning models, and drive real-time operational decisions. The company serves U.S. defense and intelligence agencies, allied governments, and a rapidly growing roster of commercial clients across healthcare, energy, manufacturing, and financial services. As of July 31, 2026, PLTR closed at $123.06, giving it a market capitalization of approximately $295 billion. The stock has declined roughly 29% year-to-date despite delivering record revenue and profitability, underscoring the tension between strong fundamentals and extreme valuation. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

What Could Drive the Next Leg Toward $200

Palantir's commercial segment is the most powerful catalyst. U.S. commercial revenue grew 121% year-over-year in the most recent quarter, and management has repeatedly raised full-year guidance. CEO Alex Karp has stated publicly that the company cannot keep up with demand, a remarkable claim for a firm already generating more than $5 billion in trailing twelve-month revenue. The partnership ecosystem is expanding rapidly—collaborations with NVDA, Google Cloud, and Accenture extend Palantir's distribution reach without proportionate increases in sales headcount. Government contracts remain sticky and are growing, with the Army's NGC2 modernization program embedding Foundry as a core data layer. Geopolitical tensions continue to drive defense spending toward AI-enabled systems, directly benefiting Palantir's government franchise. The balance sheet reinforces the bull case: roughly $8 billion in cash and marketable securities against negligible debt provides ample runway for investment and insulation against downturns.

What Could Stand in the Way

Valuation is the primary obstacle. Palantir trades at a forward price-to-earnings (P/E) ratio near 84, the highest among large-cap software companies by a wide margin. Even after a 40% drawdown from the all-time high, the stock prices in several years of flawless execution. Any sequential deceleration in revenue growth, a disappointing quarter from the commercial segment, or a reduction in forward guidance could trigger a sharp multiple compression. Insider selling adds another layer of caution—CEO Alex Karp has sold close to $2 billion worth of stock over the past two years through pre-arranged trading plans. While such sales are common among founder-led companies, the optics weigh on sentiment. Competition from hyperscalers like MSFT and AMZN, which are building competing AI orchestration layers, represents a longer-term structural risk, and a broader slowdown in enterprise AI spending could disproportionately affect a stock priced for perfection.

Analyst Views and Price Targets

Wall Street remains divided but leans constructive. Among 29 analysts covering PLTR, the consensus rating is Moderate Buy with a mean 12-month price target of approximately $192, implying roughly 56% upside from current levels. The highest target comes from Bank of America at $255, while the lowest sits at $70 from Jefferies. Notable bulls include Wedbush's Dan Ives, who maintains an Outperform rating with a $230 target and has argued Palantir could reach a $1 trillion market capitalization within several years. Rosenblatt analyst John McPeake sees PLTR at $200 within twelve months and $255 over three years. On the cautious side, Morningstar assigns a fair value estimate of $135 and a narrow economic moat, warning that the risk/reward remains poor at current multiples. The $200 question effectively sits just above the consensus analyst target, making it an ambitious but not implausible objective within a 12-to-18-month horizon.

Technical Levels Worth Watching

From a technical perspective, $200 aligns closely with the November 2025 all-time high zone around $207, forming a major resistance cluster. The stock currently trades well below both its 50-day and 200-day simple moving averages, indicating that the intermediate trend remains bearish despite the powerful underlying business performance. Near-term resistance sits near $150, an area that previously acted as support during the 2025 rally. A sustained move above $150 would likely be a prerequisite for any credible attempt at $200. On the downside, the $107 level—the 2026 low—represents critical support. A breakdown below that level would suggest deeper structural problems and would likely push the $200 target further into the future.

Using AI Daily Buy/Sell Signals for Timely Insights

Navigating a stock as volatile as Palantir requires timely and data-driven decision-making. In my own process, I turn to Tickeron’s AI Daily Buy/Sell Signals to monitor thousands of stocks and ETFs. These signals generate actionable Buy, Sell, or Hold recommendations based on shifting market conditions, technical patterns, and AI-powered analysis, helping me stay ahead of trends without manually reviewing every chart.

Final Assessment

Can Palantir realistically reach $200? The fundamentals provide a credible foundation: revenue compounding at over 70%, operating margins above 40%, a pristine balance sheet, and a commercial business gaining escape velocity. If the company continues executing at or near its current pace and the AI spending cycle remains intact, $200 is achievable within 12 to 18 months. However, the valuation leaves zero room for disappointment. The stock's premium multiple means that even a modest growth deceleration could delay the journey to $200 by years, not months. Investors should monitor quarterly revenue growth rates, U.S. commercial customer metrics, operating margin trends, and the behavior of insider selling as leading indicators. The path to $200 exists, but it runs through a narrow corridor that demands sustained excellence.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: PLTR

PLTR in upward trend: 10-day moving average broke above 50-day moving average on August 05, 2026

The 10-day moving average for PLTR crossed bullishly above the 50-day moving average on August 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 04, 2026. You may want to consider a long position or call options on PLTR as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PLTR just turned positive on August 04, 2026. Looking at past instances where PLTR's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

PLTR moved above its 50-day moving average on August 04, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where PLTR advanced for three days, in of 334 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PLTR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PLTR broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PLTR entered a downward trend on July 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PLTR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (38.911) is normal, around the industry mean (24.804). P/E Ratio (135.410) is within average values for comparable stocks, (75.105). Projected Growth (PEG Ratio) (2.293) is also within normal values, averaging (1.965). PLTR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.021). P/S Ratio (66.225) is also within normal values, averaging (144.526).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Block Inc (NYSE:XYZ), NetApp (NASDAQ:NTAP), MongoDB (NASDAQ:MDB), Twilio (NYSE:TWLO), Zscaler (NASDAQ:ZS), Okta (NASDAQ:OKTA).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 34.58B. The market cap for tickers in the group ranges from 48.8K to 3.62T. MSFT holds the highest valuation in this group at 3.62T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was 8%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 20%. BLZE experienced the highest price growth at 64%, while CSAI experienced the biggest fall at -97%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was 36%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was -30%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 72
Price Growth Rating: 54
SMR Rating: 80
Profit Risk Rating: 91
Seasonality Score: -6 (-100 ... +100)
View a ticker or compare two or three
PLTR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry ComputerCommunications

Profile
Details
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.